Lewis L. Lanier

98.6k total citations · 33 hit papers
470 papers, 72.2k citations indexed

About

Lewis L. Lanier is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Lewis L. Lanier has authored 470 papers receiving a total of 72.2k indexed citations (citations by other indexed papers that have themselves been cited), including 421 papers in Immunology, 67 papers in Molecular Biology and 63 papers in Oncology. Recurrent topics in Lewis L. Lanier's work include Immune Cell Function and Interaction (372 papers), T-cell and B-cell Immunology (275 papers) and Immunotherapy and Immune Responses (69 papers). Lewis L. Lanier is often cited by papers focused on Immune Cell Function and Interaction (372 papers), T-cell and B-cell Immunology (275 papers) and Immunotherapy and Immune Responses (69 papers). Lewis L. Lanier collaborates with scholars based in United States, France and Japan. Lewis L. Lanier's co-authors include Joseph H. Phillips, Joseph C. Sun, Adelheid Cerwenka, Jun Wu, Peter Parham, Miyuki Azuma, Joshua Beilke, Jeffrey V. Ravetch, Brian C. Corliss and Jessica A. Hamerman and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Lewis L. Lanier

466 papers receiving 70.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NK CELL RECOGNITION

2004 2.2k citations Lewis L. Lanier profile →
Innate or Adaptive Immunity? The Example of Natural Killer Cells

2011 2.0k citations Lewis L. Lanier et al. profile →
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1998 1.8k citations Véronique M. Braud, Lewis L. Lanier et al. profile →
NK CELL RECEPTORS

1998 1.4k citations Lewis L. Lanier profile →
Up on the tightrope: natural killer cell activation and inhibition

2008 1.3k citations Lewis L. Lanier profile →
Adaptive immune features of natural killer cells

2009 1.2k citations Joseph C. Sun, Joshua Beilke et al. profile →
Immune Inhibitory Receptors

2000 1.0k citations Lewis L. Lanier et al. profile →
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors

2002 969 citations Lewis L. Lanier et al. profile →
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

1986 950 citations Lewis L. Lanier et al. profile →
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs

2006 926 citations Lewis L. Lanier et al. profile →
NK cells and cancer: you can teach innate cells new tricks

2015 889 citations Lewis L. Lanier et al. profile →
Human Diversity in Killer Cell Inhibitory Receptor Genes

1997 878 citations Lewis L. Lanier et al. profile →
B70 antigen is a second ligand for CTLA-4 and CD28

1993 780 citations Lewis L. Lanier et al. profile →
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

1998 754 citations Lewis L. Lanier et al. profile →
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

1983 745 citations Lewis L. Lanier et al. profile →
Natural killer cells, viruses and cancer

2001 692 citations Adelheid Cerwenka, Lewis L. Lanier profile →
Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac Disease

2004 647 citations Bertrand Meresse, Cezary Ciszewski et al. profile →
Expansion of a unique CD57 ⁺ NKG2C ^hi natural killer cell subset during acute human cytomegalovirus infection

2011 618 citations Sandra López‐Vergès, Jeffrey M. Milush et al. Proceedings of the National Academy of Sciences profile →
Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors

1997 609 citations Lewis L. Lanier et al. profile →
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

1986 598 citations Lewis L. Lanier et al. The Journal of Experimental Medicine profile →
Comparative studies of human FcRIII-positive and negative natural killer cells.

1989 583 citations Lewis L. Lanier et al. profile →
Polymerase Chain Reaction with Single-Sided Specificity: Analysis of T Cell Receptor δ Chain

1989 565 citations Lewis L. Lanier et al. profile →
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

2010 553 citations Sandra López‐Vergès, Jeffrey M. Milush et al. Blood profile →
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice

2000 552 citations Adelheid Cerwenka, Lewis L. Lanier et al. profile →
DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes

1996 521 citations Lewis L. Lanier et al. profile →
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.

1994 521 citations Lewis L. Lanier et al. The Journal of Experimental Medicine profile →
NK cell development, homeostasis and function: parallels with CD8+ T cells

2011 518 citations Joseph C. Sun, Lewis L. Lanier profile →
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

2019 506 citations T. Deuse, Xiaomeng Hu et al. profile →
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

2011 491 citations Bree Foley, Sarah Cooley et al. Blood profile →
NKG2D Receptor and Its Ligands in Host Defense

2015 451 citations Lewis L. Lanier Cancer Immunology Research profile →
Injured sensory neuron–derived CSF1 induces microglial proliferation and DAP12-dependent pain

2015 422 citations Lewis L. Lanier et al. profile →
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals

2015 408 citations Lewis L. Lanier et al. profile →
NK cells and type 1 innate lymphoid cells: partners in host defense

2016 340 citations Lewis L. Lanier et al. profile →

Peers

Countries citing papers authored by Lewis L. Lanier

Since Specialization

Citations

This map shows the geographic impact of Lewis L. Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis L. Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis L. Lanier more than expected).

Fields of papers citing papers by Lewis L. Lanier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis L. Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis L. Lanier. The network helps show where Lewis L. Lanier may publish in the future.

Co-authorship network of co-authors of Lewis L. Lanier

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis L. Lanier. A scholar is included among the top collaborators of Lewis L. Lanier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis L. Lanier. Lewis L. Lanier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Five decades of natural killer cell discovery 2024 ·The Journal of Experimental Medicine ·Lewis L. Lanier	22
2	PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways 2024 ·Cancer Immunology Research ·Jiuling Yang, (unknown), James R. Byrnes, Lisa L. Kirkemo, (unknown), Cassandra D. Belair, Oscar A. Aguilar, Lewis L. Lanier, James A. Wells, Lawrence Fong, Robert Blelloch	7
3	CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction 2023 ·American Journal of Transplantation ·Daniel R. Calabrese, (unknown), Jonathan P. Singer, Raja Rajalingam, Steven R. Hays, Jasleen Kukreja, Lorriana E. Leard, Jeffrey A. Golden, Lewis L. Lanier, John R. Greenland	10
4	The interweaved signatures of common-gamma-chain cytokines across immunologic lineages 2023 ·The Journal of Experimental Medicine ·Alev Baysoy, Kumba Seddu, Tamara Salloum, Caleb A. Dawson, (unknown), Liang Yang, Shani T. Gal-Oz, Hadas Ner‐Gaon, Julie Tellier, (unknown), Alexander Sasse, Brian D. Brown, Lewis L. Lanier, Tal Shay, Stephen L. Nutt, Daniel F. Dwyer, Christophe Benoıst	9
5	Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression 2022 ·The Journal of Experimental Medicine ·Avishai Shemesh, Yapeng Su, Daniel R. Calabrese, Daniel Chen, Janice Arakawa‐Hoyt, Kole T. Roybal, James R. Heath, John R. Greenland, Lewis L. Lanier	23
6	NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant 2021 ·JCI Insight ·Harry Pickering, Subha Sen, Janice Arakawa‐Hoyt, Kenichi Ishiyama, (unknown), Rajesh Parmar, Richard Ahn, Gemalene Sunga, (unknown), Alexander Hoffmann, Mario C. Deng, Suphamai Bunnapradist, Joanna Schaenman, David W. Gjertson, Maura Rossetti, Lewis L. Lanier, Elaine F. Reed	20
7	The SIRPα–CD47 immune checkpoint in NK cells 2020 ·The Journal of Experimental Medicine ·T. Deuse, Xiaomeng Hu, Sean Agbor-Enoh, Moon Kyoo Jang, Malik Alawi, Ceren Saygı, Alessia Gravina, Grigol Tediashvili, Vinh Nguyen, Yuan Liu, Hannah A. Valantine, Lewis L. Lanier, Sonja Schrepfer	134
8	Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2018 ·Science Immunology ·Samuel J. Balin, Matteo Pellegrini, Eynav Klechevsky, Sohui T. Won, David I. Weiss, (unknown), Joshua K. Hakimian, Jing Lü, María Teresa Ochoa, Barry R. Bloom, Lewis L. Lanier, Steffen Stenger, Robert L. Modlin	59
9	Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide 2016 ·The Journal of Experimental Medicine ·Sharline Madera, Moritz Rapp, Matthew A. Firth, Joshua Beilke, Lewis L. Lanier, Joseph C. Sun	154
10	Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients 2014 ·Proceedings of the National Academy of Sciences ·Courtney A. Crane, Kathryn Austgen, Kristen Haberthur, (unknown), Kara White Moyes, Lia Avanesyan, Lawrence Fong, Michael J. Campbell, Stewart Cooper, Scott A. Oakes, Andrew T. Parsa, Lewis L. Lanier	144
11	CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells 2014 ·Cancer Immunology Research ·Juan Du, Sandra López‐Vergès, Brandelyn N. Pitcher, Jeffrey L. Johnson, Sin‐Ho Jung, Lili Zhou, Katharine C. Hsu, Myron S. Czuczman, Bruce D. Cheson, Lawrence Kaplan, Lewis L. Lanier, Jeffrey M. Venstrom	44
12	Proinflammatory cytokine signaling required for the generation of natural killer cell memory 2012 ·The Journal of Experimental Medicine ·Joseph C. Sun, Sharline Madera, Natalie Bezman, Joshua Beilke, Mark H. Kaplan, Lewis L. Lanier	242
13	Expansion of a unique CD57 ⁺ NKG2C ^hi natural killer cell subset during acute human cytomegalovirus infection breakdown → 2011 ·Proceedings of the National Academy of Sciences ·Sandra López‐Vergès, Jeffrey M. Milush, Brian S. Schwartz, Marcelo J. Pando, (unknown), Vanessa A. York, Jeffrey P. Houchins, Steve Miller, Sang‐Mo Kang, Phillip Norris, Douglas F. Nixon, Lewis L. Lanier	618
14	Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function breakdown → 2011 ·Blood ·Bree Foley, Sarah Cooley, Michael R. Verneris, (unknown), Julie Curtsinger, Xianghua Luo, Sandra López‐Vergès, Lewis L. Lanier, Daniel J. Weisdorf, Jeffrey S. Miller	491
15	Elevated Frequency of Gamma Interferon-Producing NK Cells in Healthy Adults Vaccinated against Influenza Virus 2007 ·Clinical and Vaccine Immunology ·Brian Long, Jakob Michaëlsson, Christopher P. Loo, (unknown), (unknown), Frederick Hecht, Lewis L. Lanier, Joan M. Chapman, Douglas F. Nixon	56
16	Reprogramming of CTLs into natural killer–like cells in celiac disease 2006 ·The Journal of Experimental Medicine ·Bertrand Meresse, Shane A. Curran, Cezary Ciszewski, Gerasim A. Orbelyan, Mala Setty, Govind Bhagat, (unknown), Maria Tretiakova, Carol E. Semrad, Emily O. Kistner, Robert Winchester, Véronique M. Braud, Lewis L. Lanier, Daniel E. Geraghty, Peter H. Green, Stefano Guandalini, Bana Jabrì	219
17	Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo 2001 ·Proceedings of the National Academy of Sciences ·Adelheid Cerwenka, Jody L. Baron, Lewis L. Lanier	481
18	Lym 7.3: New Murine Specificity Defining Third Allele of the Ly 7 Locus 1983 ·Hybridoma ·Lewis L. Lanier, Noel L. Warner	3
19	Lym 7.2: Monoclonal Antibody Defining an Alloantigen Similar or Identical to Ly 7.2 1982 ·Hybridoma ·Lewis L. Lanier, Noel L. Warner	5
20	Monoclonal Antibodies Against Rat Immunoglobulin Kappa Chains 1982 ·Hybridoma ·Lewis L. Lanier, George A. Gutman, Dorothy E. Lewis, (unknown), Noel L. Warner	233

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact